Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T74034
(Former ID: TTDI01225)
|
|||||
Target Name |
Hepatitis C virus Deoxyribonucleic acid (HCV DNA)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 1 Target-related Diseases | + | ||||
1 | Hepatitis virus infection [ICD-11: 1E50-1E51] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | ChronVac-C hepatitis C DNA vaccine | Drug Info | Phase 1/2 | Hepatitis C virus infection | [2] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Inovio Pharmaceuticals. | |||||
REF 2 | ClinicalTrials.gov (NCT00563173) Phase I/IIa Dose Ranging CHRONVAC-C Study in Chronic HCV Patients. U.S. National Institutes of Health. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.